Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial
2007

Folate Augmentation of Treatment for Depression: Study Protocol

Sample size: 730 publication Evidence: moderate

Author Information

Author(s): Roberts Seren Haf, Bedson Emma, Hughes Dyfrig, Lloyd Keith, Moat Stuart, Pirmohamed Munir, Slegg Gary, Tranter Richard, Whitaker Rhiannon, Wilkinson Clare, Russell Ian

Primary Institution: Bangor University

Hypothesis

Does folate augmentation improve the efficacy of antidepressant treatment in patients with moderate to severe depression?

Conclusion

If folic acid is shown to improve the efficacy of antidepressants, it will provide a safe, simple, and cheap way of improving the treatment of depression.

Supporting Evidence

  • One in four people experience clinical depression during their lives.
  • Patients with low folate levels respond less well to antidepressant therapy.
  • Folate is required for the synthesis of neurotransmitters implicated in depression.

Takeaway

This study is trying to find out if adding folic acid to depression treatment helps people feel better. They will check if it works for many patients.

Methodology

This is a multi-centred double blind, placebo-controlled, randomised trial of folic acid augmentation of pragmatic antidepressant treatment over 3 months.

Potential Biases

Potential biases may arise from the recruitment process and the reliance on self-reported measures.

Limitations

The study may not account for all variables affecting depression treatment response, and the generalizability may be limited to the specific populations studied.

Participant Demographics

Patients aged 18 or over with moderate to severe depression, recruited from North East Wales, North West Wales, and Swansea.

Digital Object Identifier (DOI)

10.1186/1471-244X-7-65

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication